Zoetis Inc. (NYSE:ZTS) Shares Purchased by McKinley Carter Wealth Services Inc.

McKinley Carter Wealth Services Inc. boosted its stake in Zoetis Inc. (NYSE:ZTS) by 5.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,108 shares of the company’s stock after buying an additional 105 shares during the quarter. McKinley Carter Wealth Services Inc.’s holdings in Zoetis were worth $343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in Zoetis during the 3rd quarter worth $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis in the third quarter valued at about $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Zoetis during the third quarter worth about $33,000. Dunhill Financial LLC grew its holdings in shares of Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after buying an additional 75 shares during the last quarter. Finally, Quarry LP increased its position in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after acquiring an additional 153 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the subject of a number of recent research reports. JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Morgan Stanley decreased their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, Stifel Nicolaus dropped their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $215.00.

Zoetis Stock Down 0.1 %

Shares of NYSE ZTS opened at $170.33 on Thursday. The stock has a market capitalization of $76.85 billion, a price-to-earnings ratio of 32.02, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The firm has a 50-day moving average price of $169.93 and a 200 day moving average price of $179.65. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period last year, the company posted $1.36 earnings per share. Equities research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. This is an increase from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s payout ratio is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.